Search
Consultant360 reached out to lead study author Anh P. Nguyen, PhD, from the Kaiser Permanente Institute for Health Research, to discuss a recent study which examined how exposure to prescription opioids from family members is associated with overdose risk among youth.
A 42-year-old female with a medical history significant for systemic lupus erythematous presented with dyspnea and an abnormal electrocardiogram (ECG).
An international team of researchers explored the effects of a series of rare genetic mutations that affect the development of diabetes in a new study.
After the clinical trial showed positive results, the first treatment option for adults with inflammatory arthritis in the spine has been approved.
An exaggerated emotional brain response to nonthreatening, nonemotional cues at age 14 predicted the onset of psychosis symptoms within the next 2 years.
<p><span>Various psychological and neurodevelopmental disorders occur more often among siblings of individuals with autism spectrum disorders (ASD), researchers report.</span></p>
<p>People with a genetic predisposition for high levels of low-density lipoprotein (LDL) cholesterol may be at higher risk of cardiovascular disease throughout their lives, even long into old age, a new study suggests.</p>
A 52-year-old woman has been having hot flashes 12 to 15 times a day for almost 6 months, causing a strong negative impact on her work and sleep. She has a history of stage 1 breast cancer (estrogen receptor-negative) 10 years prior.
Two recent studies reported on the potential benefits of continuous glucose monitoring in patients with type 1 diabetes who use daily insulin injections.
This COVID-19 roundup details the results of a study into the effectiveness of a new AstraZeneca vaccine, the spread of the UK variant in the United States, and how vitamin D levels affect outcomes.
Patients with first-episode psychosis who participated in an early intervention program had mortality rates 4 times lower than patients who did not take part in such a program, according to a study published online in the American Journal of Psychiatry.
In this podcast, Robert S. Rosenson, MD, from the Icahn School of Medicine at Mount Sinai in New York, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and the implications of the research for clinical practice.
Following two studies, the FDA has approved the first cellular therapy for the treatment of type 1 diabetes in patients.
The American Society for Bone and Mineral Research has released new guidance on duration of bisphosphonate treatment in patients with osteoporosis.